The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Jon Summers at email@example.com.
January 20, 2023
UsAgainstAlzheimer’s Statement on FDA Complete Response Letter for Donanemab
Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s
The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.